KRS Capital Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1910876
Bloomfield, MI
Position in REGN
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$200,886
+$200 QoQ
Shares Held
260
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KRS Capital Management, LLC holds $780,859 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,572 | $780,859 |
All Filings in REGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $200,886 | 260 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $200,686 | 260 | Shares | Sole | 2026-01-15 | |
| 2025-03-31 | $209,295 | 330 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $235,068 | 330 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $346,909 | 330 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $346,839 | 330 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $317,621 | 330 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $289,835 | 330 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $271,576 | 330 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $247,896 | 345 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $283,476 | 345 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $256,128 | 355 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $216,994 | 315 | Shares | Sole | 2022-10-21 | |
| 2022-03-31 | $220,002 | 315 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $198,928 | 315 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||